people/brainworking.jpgA new study may uncover a way to find Alzheimer's Disease in its early stages, offering more hope for prevention and control.

The New England Journal of Medicine has published a study on a new brain imaging technique that researchers found to be highly accurate in detecting Alzheimer's disease and differentiating it from natural brain aging - a key clinical step in the early assessment of the disease. Researchers at the University of California, Los Angeles (UCLA) who conducted the study will now work with Siemens Medical Solutions to open clinical trials of the imaging agent as a first step towards making this technology available to patients. he imaging agent is the first such marker designed to identify Alzheimer's disease pathology specifically, and differentiate it from normal aging. Currently, the only way to confirm Alzheimer's disease is through autopsy. However, this new imaging marker is designed to be injected into the bloodstream, and seek out Alzheimer's-specific protein deposits in the brain, causing them to light up under an imaging technology called positron emission tomography (PET).